Tenaya Therapeutics

📍 South San Francisco, United States🗓 Founded 2016👥 135 employees💰 Last funded Mar 2020
Biotechnology Research🌐 tenayatherapeutics.com
Website LinkedIn
Tenaya Therapeutics is a clinical stage biotechnology company. The Company was founded in 2016 by leading cardiovascular scientists from the David J. Gladstone Institutes and the University of Texas Southwestern Medical Center. We are a biotechnology company committed to a bold mission: to discover, design, develop and deliver curative therapies that address the underlying drivers of heart disease. Our vision is to change the treatment paradigm for heart disease, and in doing so improve and extend the lives of millions of individuals and families fighting this debilitating disease. We are advancing a pipeline of disease-modifying therapies developed using our product platforms and core internal capabilities to target defined sub-populations of patients with rare or highly prevalent forms of heart disease.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Tenaya Therapeutics?
Tenaya Therapeutics has 2 investors on record on gritt.io, 2 mid-stage.
When did Tenaya Therapeutics last raise funding?
The most recent investment in Tenaya Therapeutics recorded on gritt.io was in March 2020.
When was Tenaya Therapeutics founded?
Tenaya Therapeutics was founded in 2016.
What industry is Tenaya Therapeutics in?
Tenaya Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Tenaya Therapeutics based?
Tenaya Therapeutics is headquartered in South San Francisco, United States.